{"id":"NCT05559476","sponsor":"GlaxoSmithKline","briefTitle":"A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above","officialTitle":"A Phase 3, Open-label, Randomized, Controlled, Multicountry Study to Evaluate the Immune Response, Safety and Reactogenicity of RSVPreF3 OA Investigational Vaccine When Co-administered With FLU HD Vaccine in Adults Aged 65 Years and Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-10-20","primaryCompletion":"2023-03-07","completion":"2023-08-15","firstPosted":"2022-09-29","resultsPosted":"2024-04-04","lastUpdate":"2024-09-24"},"enrollment":1029,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Respiratory Syncytial Virus Infections"],"interventions":[{"type":"BIOLOGICAL","name":"RSVPreF3 OA investigational vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"FLU HD vaccine","otherNames":[]}],"arms":[{"label":"Co-Ad Group","type":"EXPERIMENTAL"},{"label":"Control Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the immunogenicity, safety and reactogenicity of the RSVPreF3 OA investigational vaccine when co-administered with the high dose quadrivalent influenza (FLU HD) vaccine in adults aged 65 years and above compared to separate administration of the vaccines.","primaryOutcome":{"measure":"RSV-A Neutralizing Titers Expressed as Group Geometric Mean Titers (GMTs)","timeFrame":"At 1 month after the RSVPreF3 OA vaccine dose (Day 31 for the Co-Ad Group and Day 61 for the Control Group)","effectByArm":[{"arm":"Co-Ad Group","deltaMin":5876.3,"sd":null},{"arm":"Control Group","deltaMin":6935.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":20},"locations":{"siteCount":46,"countries":["United States"]},"refs":{"pmids":["38981954"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":516},"commonTop":["Injection site pain","Myalgia","Fatigue","Headache","Arthralgia"]}}